Nomura Holdings
ARQT icon

Nomura Holdings’s Arcutis Biotherapeutics ARQT Stock Holding History

Nomura Holdings’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,943
Closed -$541K – 1794
2026
Q1 		$541K Buy
+22,943
New +$586K ﹤0.01% 1341
2023
Q1 		– Sell
-585
Closed -$9K – 1446
2022
Q4 		$9K Hold
585
– – ﹤0.01% 1374
2022
Q3 		$11K Hold
585
– – ﹤0.01% 1524
2022
Q2 		$13K Buy
+585
New +$12K ﹤0.01% 1641

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Holdings's ARQT Position: Q2 2026 in Review

Nomura Holdings sold out of Arcutis Biotherapeutics (ARQT) in Q2 2026, closing a stake of 22,943 shares — an estimated $541K sold.

Nomura Holdings first reported a position in ARQT in Q2 2022 and held it in 4 quarters. The position peaked at $541K in Q1 2026. 272 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • Nomura Holdings reported no remaining Arcutis Biotherapeutics position as of Q2 2026 after selling out during the quarter.
  • Nomura Holdings sold 22,943 Arcutis Biotherapeutics shares in Q2 2026, an estimated $541K.
  • Nomura Holdings first reported a position in Arcutis Biotherapeutics in Q2 2022 and held it in 4 quarters.
  • Nomura Holdings's Arcutis Biotherapeutics position peaked at $541K in Q1 2026.
  • 272 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.